stdi glp 1 stdei glp-1 Dr. Stephanie's GLP-1 Buddy Zero

Tesamorelin is a GHRH analog, a signal that asks the pituitary to release the bodys own growth hormone

Although easier said than done, try to maintain a consistent bedtime, practice mindfulness, and develop strategies to manage stress

Treatment should be discontinued if inadequate response occurs: less than 5% weight loss after 6 months for Wegovy or 12 weeks for Saxenda at maintenance doses

Short bursts of telomerase activation appear sufficient to produce lasting effects on telomere length and cellular function

In patients with clinical ASCVD and possible SASEs who have failed at least 2 (and preferably 3) statins, including a trial of 1 attempt at the lowest approved dose or using alternative statin dosing, or who still have not achieved adequate reduction in LDL-C or nonHDL-C on maximally tolerated statin therapy, a trial of ezetimibe or a PCSK9 mAb may be considered as first-line nonstatin therapy (see Figure 7), depending on the patients clinical scenario